Parallax Volatility Advisers
APLS

Parallax Volatility Advisers’s Apellis Pharmaceuticals APLS Stock Holding History

Parallax Volatility Advisers’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-24,443
Closed -$570K – 1589
2025
Q2 		$423K Sell
24,443
-3,907
-14% -$72.3K ﹤0.01% 1215
2025
Q1 		$620K Buy
+28,350
New +$783K ﹤0.01% 1150
2024
Q1 		– Sell
-39,392
Closed -$2.36M – 1806
2023
Q4 		$2.36M Buy
+39,392
New +$2M ﹤0.01% 1110
2023
Q2 		– Sell
-89
Closed -$7.68K – 2367
2023
Q1 		$5.87K Sell
89
-31,791
-100% -$1.83M ﹤0.01% 2456
2022
Q4 		$1.65M Sell
31,880
-45,273
-59% -$2.4M ﹤0.01% 1474
2022
Q3 		$5.27M Buy
77,153
+29,090
+61% +$1.72M 0.01% 998
2022
Q2 		$2.17M Buy
48,063
+48,053
+480,530% +$2.19M ﹤0.01% 1311
2022
Q1 		$1K Buy
+10
New +$441 ﹤0.01% 2770
2020
Q3 		– Sell
-393
Closed -$13K – 3028
2020
Q2 		$13K Sell
393
-14,003
-97% -$450K ﹤0.01% 2602
2020
Q1 		$386K Buy
14,396
+12,152
+542% +$431K ﹤0.01% 1813
2019
Q4 		$69K Buy
+2,244
New +$62.1K ﹤0.01% 2191
2018
Q1 		– Sell
-1,680
Closed -$36K – 2224
2017
Q4 		$36K Buy
+1,680
New +$24.7K ﹤0.01% 3387

Other funds holding APLS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Parallax Volatility Advisers's APLS Position: Q3 2025 in Review

Parallax Volatility Advisers sold out of Apellis Pharmaceuticals (APLS) in Q3 2025, closing a stake of 24,443 shares — an estimated $570K sold.

Parallax Volatility Advisers first reported a position in APLS in Q4 2017 and held it in 12 quarters. The position peaked at $5.27M in Q3 2022. 273 funds tracked by Wall St. Rank hold APLS as of Q3 2025.

  • Parallax Volatility Advisers reported no remaining Apellis Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Parallax Volatility Advisers sold 24,443 Apellis Pharmaceuticals shares in Q3 2025, an estimated $570K.
  • Parallax Volatility Advisers first reported a position in Apellis Pharmaceuticals in Q4 2017 and held it in 12 quarters.
  • Parallax Volatility Advisers's Apellis Pharmaceuticals position peaked at $5.27M in Q3 2022.
  • 273 funds tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q3 2025.

Based on Parallax Volatility Advisers's 13F filing for Q3 2025, filed 14 Nov 2025.